U.S.: China Cutting Red Tape for Innovative Drug Imports

Drug Industry Daily
A A
China has agreed to streamline its regulatory processes and cut red tape for imports of new drugs, a move that should benefit the U.S. pharmaceutical industry, the U.S. Commerce Department says.

To View This Article:

Login

Subscribe To Drug Industry Daily